Nearly 80% of the SKBR3 breast cancer cells were highly positive for the expression of both drug transporter proteins ABCG2/CD338 and MDR1/CD243, while 10% of the MCF7 cells expressed CD338/ABCG2 (Figure 1A). This evidence concerns the gene ABCB1 and breast cancer.